论文部分内容阅读
目的:分析穴位埋线结合布地奈德吸入治疗支气管哮喘的临床效果。方法:选取本院收治的支气管哮喘患者108例,将其随机分为观察组与对照组,各54例,对照组给予布地奈德吸入治疗,在对照组基础上观察组结合穴位埋线治疗,观察两组患者哮喘发作情况及肺功能变化情况。结果:观察组总有效率为96.3%,明显高于对照组的83.3%(P<0.05);治疗前,两组患者中医症候评分及哮喘发作次数比较,差异无统计学意义(P>0.05);治疗后,观察组患者的中医症候评分及哮喘发作次数均少于对照组,差异具有统计学意义(P<0.05);治疗前,两组患者1秒用力呼气容积(FEV1)、用力肺活量(FVC)、FEV1/FVC等肺功能指标比较,差异无统计学意义(P>0.05);治疗后,两组患者FEV1、FVC、FEV1/FVC等肺功能指标均明显改善,差异具有统计学意义(P<0.05);且治疗后,观察组患者观察组患者FEV1、FVC、FEV1/FVC与对照组比较,差异具有统计学意义(P<0.05)。结论:穴位埋线结合布地奈德吸入治疗支气管哮喘的临床效果显著。
Objective: To analyze the clinical effect of catgut embedding combined with budesonide inhalation in the treatment of bronchial asthma. Methods: A total of 108 patients with bronchial asthma admitted to our hospital were randomly divided into observation group and control group, 54 cases in each group. The control group was treated with budesonide inhalation. On the basis of the control group, The asthma attack and the changes of pulmonary function in two groups were observed. Results: The total effective rate in the observation group was 96.3%, which was significantly higher than that in the control group (83.3%, P <0.05). Before treatment, there was no significant difference in TCM symptom scores and asthma exacerbations between the two groups (P> 0.05) ; After treatment, the scores of TCM symptoms and the number of asthma attacks in the observation group were less than those in the control group (P <0.05); before treatment, forced expiratory volume (FEV1), forced vital capacity (FVC), FEV1 / FVC and other lung function indexes, the difference was not statistically significant (P> 0.05); After treatment, the two groups of patients FEV1, FVC, FEV1 / FVC and other lung function indicators were significantly improved, the difference was statistically significant (P <0.05). After treatment, FEV1, FVC and FEV1 / FVC in the observation group were significantly different from those in the control group (P <0.05). Conclusion: Catgut embedding in combination with budesonide has a significant clinical effect on bronchial asthma.